ABG Sundal Collier acted as financial advisor to Kverva and the founders in connection with the sale of PatoGen to Fürst Medical Laboratory

On Wednesday 4 August 2021, Fürst Medical Laboratory’s acquisition of PatoGen was announced. ABG Sundal Collier acted as financial advisor to the sellers, Kverva Industrier, Aspehaug Holding and Devold Holding, in relation to the transaction.
PatoGen is the leading provider of preventive and diagnostic fish health analyses for use in aquaculture in Norway and Scotland. With experience for the past 70 years focusing on superior service and high quality in human health diagnostics, Fürst is a market leader and among the largest medical laboratory service providers in Northern Europe.